• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Connecting Researchers and Research

Sign in/Register
  • About
        • Our Mission
          • 2025 Vision
          • ORCID Trust
          • Annual Reports
        • Team
          • ORCID Board
          • ORCID Team
          • Work with Us!
        • Services
          • Member Portal
          • Annual data files
          • Member API
          • Public API
          • ORCID Registry
        • Governance
          • Bylaws
          • Board Elections
        • Policies
          • Privacy Policy
          • Dispute Procedures
          • Public Client Terms of Service
          • Open Source Project License
          • Public Data File Use Policy
          • Terms of Use
          • Brand Guidelines
  • For Researchers
        • Benefits for Researchers
        • Researcher FAQ
        • Video Tutorials
        • Sign in / Register
        • Get Help
  • Membership
        • Membership Benefits
          • Benefits for Funders
          • Benefits for Publishers
          • Benefits for Research Organizations
          • Benefits for Research Resources
        • Get Membership
        • Member List
        • ORCID Map
        • Membership Comparison
          • Basic Membership
          • Premium Membership
          • ORCID Consortia
        • ORCID Consortia
          • Consortia Agreement
          • Consortia Onboarding Checklist
          • Roles and Responsibilities of ORCID Consortia
  • Documentation
        • Features
          • Member Portal
          • Member API
          • Public API
          • ORCID Registry
          • Annual Data Files
        • Workflows
          • Journal Articles
          • Employment
          • Peer Review
          • Funder and Grants
          • View More
        • Integration Guide
          • Getting Started with Your Integration
          • Sandbox Testing Server
          • Registering a Member API Client
          • Integration and API FAQ
          • View More
        • API Tutorials
          • Get an Authenticated ORCID iD
          • Read Data on a Record
          • Add and Update Data on an ORCID record
          • Hands On with the ORCID API
          • View More
  • Resources
        • ORCID Community
        • Community Programs
          • Certified Service Providers
          • ORCID API Users Group
          • Historical Task Forces, Working Groups, and Steering Groups
        • Get Involved
          • Community Groups
          • Developers
          • Give Feedback
          • ORCID API Users Group
        • Member Resources
          • ORCID Enabled Systems
          • Publishers Open Letter
          • Funders Open Letter
          • Standard Member Agreement
          • Outreach Resources
          • Register a Sandbox API Client
          • Register a Production API Client
  • News & Events
        • News
          • ORCID News
          • Member News
          • Consortia News
          • Integration News
          • Blog
          • Release Notes
        • Events
          • Events Calendar
          • Webinars

ORCID Mandate Trial at Springer Nature

February 21, 2018 By Elisa De Ranieri

This post was co-authored by Elisa De Ranieri (Head of Editorial Process and Data Analytics, Nature Journals) and Alison Mitchell (Chief Publishing Adviser, Springer Nature, and ORCID Board member)

Springer Nature was one of the founding members of ORCID, and since 2012 we have encouraged our authors to submit verified ORCID identifiers and we display them on published papers. This ensures authors get credit for their publications, and contributes to improving the transparency of scholarly communication by disambiguating name homonyms. To further support the uptake of ORCID, in 2017 Springer Nature engaged in a trial mandating ORCID identifiers for corresponding authors of primary research manuscripts at 46 journals across our portfolios.

The trial ran from April 27 for 6 months and the mandate was applied at different stages of the manuscript processing: 14 Nature-branded research journals required iDs at acceptance, while 10 BioMed Central (BMC) and 22 Springer journals did so at initial submission. Corresponding authors were able to share their ORCID identifier in the manuscript tracking system (via the ORCID API); without this step the submission would not proceed to the next stage.

A positive outcome

The response from the research communities was a positive one. There were no instances reported of authors who refused to provide an ORCID identifier at acceptance for the 14 Nature-branded journals, and no observable drop in submissions to the BMC and Springer journals participating in the trial that could be related to the mandate.

For the 14 Nature-branded titles, the percentage of corresponding authors on published papers providing an ORCID identifier grew over the course of the trial from 37% to 96% (Fig. 1). We didn’t quite reach 100% compliance, but this was due to technical hiccups rather than authors refusing to comply. As a comparison, for Nature-branded titles that did not take part in the trial this percentage increased from 26% to 45%. This underlies the effectiveness of the trial but also shows that the positive effects of the trial leaked to other Nature titles as general awareness grew.

Figure 1 Fraction of published papers with at least one corresponding authors providing a ORCID identifier as a function of time for the duration of the trial

 

 

 

 

 

For the 32 BMC and Springer journals in the trial, it was not possible to track the uptake of ORCID identifiers for corresponding authors separately from contributing authors. However, by comparing the trend in the fraction of authors with an ORCID identifier for journals participating in the trial with that for all other journals, the impact of the trial is evident: the increase in ORCID uptake was 2.5 times faster for journals in the trial (Fig. 2).

Figure 2 Fraction of authors providing a ORCID identifier at initial submission as a function of time for the duration of the trial 

 

 

 

 

 

The positive impact of the trial on the Nature-branded titles has been quite remarkable. A sharp increase in the rate with which new user accounts on the manuscript tracking systems are linked to ORCID correlates with the start of the trial (Fig. 3).

Figure 3 Fraction of user accounts on the manuscript tracking systems (MTSs) with a linked ORCID account. The graph includes data from the MTSs of Nature-branded titles and all other journals hosted on www.nature.com. The duration of the trial is indicated by the blue arrow. The black line is a trend line for behaviour prior to the trial start

 

 

 

Next steps

Given the success of this initiative, the trial did not end and is still ongoing for the journals that originally took part. In addition, Springer Nature is now looking to extend the mandate to more journals and evaluating whether to experiment with a mandate for contributing authors. It will also be interesting to investigate the differences in attitudes towards a mandate among the various research communities. Improvements in the technical systems and workflows will hopefully reduce the number of issues that might affect the success of a broader mandate.

Researchers are more and more aware of the benefits of using ORCID as a single identifier for all their research output, and they seemed willing to engage with this mandate. Slowly but surely, Springer Nature is on the path to have all of our authors registered with ORCID!

 
Blog

Filed Under: News

Primary Sidebar

Search

Sign up for blog updates

We will only use your email to notify you when we have new blog posts. You can unsubscribe at any time. See our Privacy Policy for more information.

Check your inbox or spam folder to confirm your subscription.

Recent Posts

  • 2020: A Look Back As We Venture Forward
  • New Integration – GIST
  • New Integration – University of Victoria
  • New Integration – Vidatum Technologies
  • New Integration – Mendel University in Brno

Blog Posts by Category

  • Consortia News (39)
  • Integration News (48)
  • Member News (30)
  • News (429)
  • ORCID News (192)
  • Release Notes (74)
ORCID logo

CC0 The text of this website is published under a CC0 license Images and marks are subject to copyright and trademark protection.

  • About ORCID
  • Privacy Policy
  • Terms of Use
  • Accessibility Statement
  • Contact us
  • Dispute procedures
  • Brand Guidelines
ORCID uses cookies to improve your experience and to help us understand how you use our websites. Learn more about how we use cookies. Dismiss